SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-033863
Filing Date
2015-05-05
Accepted
2015-05-05 06:01:00
Documents
11
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a15-7157_110q.htm 10-Q 1041723
2 EX-31.1 a15-7157_1ex31d1.htm EX-31.1 13988
3 EX-31.2 a15-7157_1ex31d2.htm EX-31.2 13993
4 EX-32.1 a15-7157_1ex32d1.htm EX-32.1 7024
5 EX-32.2 a15-7157_1ex32d2.htm EX-32.2 7078
  Complete submission text file 0001104659-15-033863.txt   5189085

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ptct-20150331.xml EX-101.INS 719195
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ptct-20150331.xsd EX-101.SCH 28098
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ptct-20150331_cal.xml EX-101.CAL 36128
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ptct-20150331_def.xml EX-101.DEF 113195
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ptct-20150331_lab.xml EX-101.LAB 343752
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ptct-20150331_pre.xml EX-101.PRE 233358
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Filer) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35969 | Film No.: 15830337
SIC: 2834 Pharmaceutical Preparations